Apricus Biosciences, Inc. (Nasdaq:APRI), a pharmaceutical company focusing on the development and commercialization of novel therapeutics for men's and women's health, today announced the launch of Vitaros, Apricus' novel topical on-demand treatment ... Individual.com, 4 weeks ago
Apricus Biosciences (APRI) Announces Appointment Of Sandford D. Smith To Board Of Directors - FierceBiotech, 2 weeks ago
Apricus Biosciences Enters Into Common Stock Purchase Agreement With Aspire Capital - Morningstar.com, 2 weeks ago
1 images for "sandoz inc"
Case Name: United Therapeutics Corp. v. Sandoz, Inc. , Case No. 12-cv-01617, 2014 U.S. Dist. LEXIS 52353 (D.N.J. Apr. 16, 2014) (Sheridan, J.) Drug Product and Patent(s)-in-Suit: Remodulin® (treprostinil sodium); U.S. Patent No. 7,999,007 ...JD Supra, 2 weeks ago
InnoPharma, Inc., a privately held, sterile product development company, announced that its Abbreviated New Drug Application (ANDA) for decitabine for injection, a generic version of Eisai Inc.'s Dacogen has received the approval from the US Food ...PharmaBiz, 5 hours ago Dacogen generic approved in U.S. for treatment of myelodysplastic syndromes & anemia MedCity News, 2 days ago InnoPharma receives FDA approval for generic DACOGEN News-Medical.Net, 2 days ago InnoPharma : FDA Okays Decitabine For Injection, Generic Version Of Dacogen RTTNews.com, 2 days ago
Aug 29 (Reuters) - United Therapeutics Inc shares soared on Friday after the company won a court ruling in a patent dispute that blocks Novartis AG from selling a generic version of its best-selling Remodulin hypertension drug. In afternoon ...CNBC, 2 days ago United Therapeutics Wins Against Novartis In Court Ruling Bidness Etc, 2 days ago
More from: , ACQ Magazine...and 1 other sources
Momenta Pharmaceuticals ( MNTA ) announced that the FDA has accepted partner Sandoz's, a Novartis ( NVS ) company, abbreviated new drug application ( ANDA ) for the generic version of Teva Pharmaceutical Industries Ltd.'s ( TEVA ) three-times-a-week ...Yahoo! Finance, 2 days ago
| Comments (0) The market is very bullish on Hospira (NYSE: HSP ) , which has rallied impressively over the past 12 months. Source: YCharts. The maker of specialty injectable pharmaceuticals and medical devices has certainly been on fire -- ...Motley Fool, 1 week ago
Pharmaceutical and medication delivery company Hospira, Inc. (HSP: Quote) revealed in a regulatory filing on Wednesday that a federal judge has granted a temporary restraining order against the U.S. Food and Drug Administration or FDA's, decision to ...RTTNews.com, 1 week ago Hospira scores temporary win in lawsuit versus FDA Formulary Journal, 1 week ago Hospira Granted Restraining Order Against FDA Approval Of Generics Bidness Etc, 1 week ago U.S. judge sides with Hospira in generic Precedex patent lawsuit MedCity News, 1 week ago
Apricus Biosciences, Inc. ( APRI ) announced the launch of its sole approved product, Vitaros in Germany. Vitaros is an on-demand topical cream formulation for treating patients suffering from erectile dysfunction ED). In Jun 2013, Vitaros had ...Yahoo! Finance, 1 week ago
MarketResearchReports.Com: Global Biosimilars/Follow-on-Biologics Market is Expected to Reach $35 Billion by 2020, Reveals New Report
Market Research Reports, Inc. has announced the addition of "Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, ...Individual.com, 2 weeks ago Market Research Reports, Inc. (www.marketresearchreports.com): MarketResearchReports.Com: Global Biosimilars/Follow-on-Biologics Market is Expected to Reach $35 Billion by 2020, Reveals New Report BusinessWeek, 2 weeks ago Analyzing the Global Market for Active Pharmaceutical Ingredients - 2014 Individual.com, 3 hours ago Research and Markets: Analyzing the Global Market for Active Pharmaceutical Ingredients - 2014 BioMedReports, 1 hour ago
GEVO, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations.
(Edgar Glimpses Via Acquire Media NewsEdge) Forward-Looking Statements This report contains forward-looking statements. When used anywhere in this Quarterly Report on Form 10-Q (this "Report"), the words "expect," "believe," "anticipate," ...TMC Net, 2 weeks ago MOMENTA PHARMACEUTICALS INC - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations. TMC Net, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!